1. Home
  2. NQP vs IMRX Comparison

NQP vs IMRX Comparison

Compare NQP & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Pennsylvania Quality Municipal Income Fund

NQP

Nuveen Pennsylvania Quality Municipal Income Fund

HOLD

Current Price

$11.90

Market Cap

442.1M

Sector

Finance

ML Signal

HOLD

Logo Immuneering Corporation

IMRX

Immuneering Corporation

HOLD

Current Price

$6.54

Market Cap

366.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NQP
IMRX
Founded
1990
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
442.1M
366.1M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
NQP
IMRX
Price
$11.90
$6.54
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$17.20
AVG Volume (30 Days)
58.4K
1.3M
Earning Date
01-01-0001
11-12-2025
Dividend Yield
3.21%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.65
$1.10
52 Week High
$11.89
$10.08

Technical Indicators

Market Signals
Indicator
NQP
IMRX
Relative Strength Index (RSI) 40.88 51.84
Support Level $11.82 $6.49
Resistance Level $12.05 $6.98
Average True Range (ATR) 0.08 0.43
MACD -0.02 0.09
Stochastic Oscillator 26.32 70.26

Price Performance

Historical Comparison
NQP
IMRX

About NQP Nuveen Pennsylvania Quality Municipal Income Fund

Nuveen Pennsylvania Quality Municipal Income Fund is a closed-end fixed income mutual fund. The fund's investment objectives are (i) to provide current income exempt from regular federal income tax, the federal alternative minimum tax applicable to individuals and California income tax and (ii) to enhance portfolio value relative to the municipal bond market by investing in tax- exempt municipal securities that the Fund's investment adviser and/or the Fund's sub-adviser, believes are underrated or undervalued or that represent municipal market sectors that are undervalued. The fund prominenty invests in tax-exempt municipal bonds from Pennsylvania that are investment grade.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: